Cargando…
Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)
Autores principales: | Page, David B, McArthur, Heather, Dong, Zhiwan, Wong, Phillip, Emerson, Ryan, Mu, Zhenyu, Zhao, Chunjun, Comstock, Christopher, Morris, Elizabeth, Comen, Elizabeth, Kotin, Alan, Sung, Janice, Brogi, Edi, Morrow, Monica, Solomon, Stephen, Sacchini, Virgilio, Maybody, Majid, Neville, Deirdre, Diab, Adi, Sharma, Padmanee, Robins, Harlan, Patil, Sujata, Wolchok, Jedd D, Hudis, Clifford, Norton, Larry, Allison, James, Yuan, Jianda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288457/ http://dx.doi.org/10.1186/2051-1426-2-S3-P138 |
Ejemplares similares
-
Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients
por: Page, David B, et al.
Publicado: (2015) -
Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI)
por: Bartell, Heddy, et al.
Publicado: (2015) -
Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
por: Page, David B, et al.
Publicado: (2014) -
Pre-treatment serum vascular endothelial growth factor is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab
por: Yuan, Jianda, et al.
Publicado: (2013) -
Simplicity at the cost of predictive accuracy in diffuse large B‐cell lymphoma: a critical assessment of the R‐IPI, IPI, and NCCN‐IPI
por: Biccler, Jorne, et al.
Publicado: (2017)